When cancer spreads from a primary tumor to new sites throughout the body, it undergoes changes that increase its genetic ...

The SWOG S2302 Pragmatica-Lung trial, which broke new ground with its streamlined pragmatic design, unusually broad ...

When cancer spreads from a primary tumor to new sites throughout the body, it undergoes changes that increase its genetic ...

The addition of low-intensity electric tumor treating fields (TTFields) therapy to first-line standard chemotherapy was ...

Asandeutertinib is a derivative of Tagrisso designed to avoid certain toxic side effects in patients with EGFR-mutated NSCLC.

A phase 2 trial found that adding bevacizumab to alectinib significantly delayed disease progression, protected against brain ...

Amplia Therapeutics is making strides with its candidate that works on the anti-fibrotic path to tackling pancreatic cancer.

“Last week, President Joe Biden was seen for a new finding of a prostate nodule after experiencing increasing urinary ...

Discover the subtle warning signs of metastatic cancer that are often overlooked. Learn how early detection of cancer spread ...

"Go and see your doctor if you've got anything that you're concerned about – that's what a [doctor] is for," Brian Gemmell said Getty A lung cancer patient had no respiratory symptoms before his ...

Major Finding: Brain metastases that arise from various primary sites characteristically harbor chromosomal instability and an immunosuppressive stromal/immune composition.

I’m referring to the pending announcement of the first clinical data from Summit Therapeutics and its buzzy PD-1-VEGF antibody ivonescimab derived from lung cancer patients in the U.S. and other ...